These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18359028)

  • 41. Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021.
    Mulligan K; Harris DR; Monte D; Stoszek S; Emmanuel P; Hardin DS; Kapogiannis BG; Worrell C; Meyer WA; Sleasman J; Wilson CM; Aldrovandi GM;
    Clin Infect Dis; 2010 Jan; 50(1):106-14. PubMed ID: 19947855
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cardiovascular risk marker asymmetric dimethylarginine is elevated in asymptomatic, untreated HIV-1 infection and correlates with markers of immune activation and disease progression.
    Hudson CL; Zemlin AE; Ipp H
    Ann Clin Biochem; 2014 Sep; 51(Pt 5):568-75. PubMed ID: 24142400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating the use of procalcitonin in an asymptomatic, HIV-infected antiretroviral therapy-naïve, South African cohort.
    Phatlhane DV; Ipp H; Erasmus RT; Zemlin AE
    Clin Chem Lab Med; 2016 Mar; 54(3):501-8. PubMed ID: 26485747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dyslipidemia, chronic inflammation, and subclinical atherosclerosis in children and adolescents infected with HIV: The PositHIVe Health Study.
    Augustemak de Lima LR; Petroski EL; Moreno YMF; Silva DAS; Trindade EBMS; Carvalho AP; Back IC
    PLoS One; 2018; 13(1):e0190785. PubMed ID: 29320547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment.
    Bernal E; Serrano J; Perez A; Valero S; Garcia E; Marín I; Muñoz A; Verdú JM; Vera C; Cano A
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19723. PubMed ID: 25397469
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein.
    Dieset I; Hope S; Ueland T; Bjella T; Agartz I; Melle I; Aukrust P; Røssberg JI; Andreassen OA
    Schizophr Res; 2012 Sep; 140(1-3):169-74. PubMed ID: 22817875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epi-aortic lesions, pathologic FMD, endothelial activation and inflammatory markers in advanced naïve HIV-infected patients starting ART therapy.
    Bellacosa C; Maggi P; Volpe A; Altizio S; Ladisa N; Cicalini S; Viglietti R; Chirianni A; Bellazzi L; Zanaboni D; Maserati R; Martinelli C; Corsi P; Sofia S; Celesia M; Sozio F; Abbrescia N; Angarano G
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19545. PubMed ID: 25394052
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors.
    Saito M; Ishimitsu T; Minami J; Ono H; Ohrui M; Matsuoka H
    Atherosclerosis; 2003 Mar; 167(1):73-9. PubMed ID: 12618270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concurrent use of Antiretroviral and African traditional medicines amongst people living with HIV/AIDS (PLWA) in the eThekwini Metropolitan area of KwaZulu Natal.
    Mncengeli S; Manimbulu NM; Panjasaram N
    Afr Health Sci; 2016 Dec; 16(4):1118-1130. PubMed ID: 28479905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammatory Biomarkers and Carotid Thickness in HIV Infected Patients under Antiretroviral Therapy, Undetectable HIV-1 Viral Load, and Low Cardiovascular Risk.
    Leite KME; Santos Júnior GG; Godoi ETAM; Vasconcelos AF; Lorena VMB; Araújo PSR; Lima KO; Lacerda HR
    Arq Bras Cardiol; 2020 Jan; 114(1):90-97. PubMed ID: 31664319
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors.
    Ryu SY; Lee YS; Park J; Kang MG; Kim KS
    J Korean Med Sci; 2005 Jun; 20(3):379-83. PubMed ID: 15953856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic syndrome in Zambian adults with human immunodeficiency virus on antiretroviral therapy: Prevalence and associated factors.
    Hamooya BM; Mulenga LB; Masenga SK; Fwemba I; Chirwa L; Siwingwa M; Halwiindi H; Koethe JR; Lipworth L; Heimburger DC; Musonda P; Mutale W
    Medicine (Baltimore); 2021 Apr; 100(14):e25236. PubMed ID: 33832083
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses.
    Miller BJ; Kandhal P; Rapaport MH; Mellor A; Buckley P
    Brain Behav Immun; 2015 Mar; 45():28-35. PubMed ID: 25542737
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex Differences in High Sensitivity C-Reactive Protein in Subjects with Risk Factors of Metabolic Syndrome.
    Garcia VP; Rocha HN; Sales AR; Rocha NG; da Nóbrega AC
    Arq Bras Cardiol; 2016 Mar; 106(3):182-7. PubMed ID: 27027366
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
    Koethe JR; Grome H; Jenkins CA; Kalams SA; Sterling TR
    AIDS; 2016 Jan; 30(1):83-91. PubMed ID: 26418084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inflammation markers and the risk of hypertension in people living with HIV.
    Ou-Yang H; Fu HY; Luo Y; Xu ZY; Liu J; Gao R; Duan JY; Mao YC; Li HJ; Du YR
    Front Immunol; 2023; 14():1133640. PubMed ID: 37025998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic abnormalities in adult HIV infected population on antiretroviral medication in Malaysia: a cross-sectional survey.
    Hejazi N; Rajikan R; Choong CL; Sahar S
    BMC Public Health; 2013 Aug; 13():758. PubMed ID: 23947428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study.
    Boger MS; Shintani A; Redhage LA; Mitchell V; Haas DW; Morrow JD; Hulgan T
    J Acquir Immune Defic Syndr; 2009 Dec; 52(4):480-7. PubMed ID: 19911471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Higher Levels of Cystatin C in HIV/AIDS Patients with Metabolic Syndrome.
    Dragović G; Srdić D; Al Musalhi K; Soldatović I; Kušić J; Jevtović D; Nair D
    Basic Clin Pharmacol Toxicol; 2018 Apr; 122(4):396-401. PubMed ID: 29024496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients.
    Dave JA; Levitt NS; Ross IL; Lacerda M; Maartens G; Blom D
    PLoS One; 2016; 11(3):e0151911. PubMed ID: 26986065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.